Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayFeb 09, 2017 11:44 am

NetworkNewsBreaks – Investors Applaud Marchex’s (NASDAQ: MCHX) Partnership with Facebook (NASDAQ: FB) to Launch Omnichannel Analytics Cloud; Shares Higher

Shares of Marchex (NASDAQ: MCHX) are up 16% after the mobile advertising analytics company announced its partnership with Facebook (NASDAQ: FB) that will integrate across its social analytics solution and into an industry-leading analytics platform called the Marchex Omnichannel Analytics Cloud. The integrated technology is designed to help marketers connect offline customer behavior to online marketing activity. “Online advertising has long struggled to connect digital engagements with accurate attribution to offline interactions and sales. While the influence of mobile phones and reach of digital channels like Facebook is undeniable, we also know that a large portion of sales are still…

Continue Reading

ThursdayFeb 09, 2017 9:59 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Hosting Webinar on February 23

eXp World Holdings, Inc. (OTCQB: EXPI), holding company for eXp Realty LLC, this morning announced its plans to host a corporate update webinar on Thursday, February 23, 2017, at 8:30 AM Pacific Time. The call, which is to be hosted by Glenn Sanford, chairman and CEO of EXPI, and Alan Goldman, the company’s CFO, will feature a look into EXPI’s sustained growth in the real estate sector, as well as an overview of the company’s unique business model and some insight into its key milestones. To access the call, interested investors should dial 1-888-221-3884 if within the United States or…

Continue Reading

ThursdayFeb 09, 2017 9:52 am

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Prices $5M Public Offering; Shares Lower

Moleculin Biotech (NASDAQ: MBRX) shares tumbled 20% at market open after the company priced an underwritten public offering of its securities. The offering is comprised of 3,710,000 units at a public offering price of $1.35 per unit. Moleculin anticipates gross proceeds of approximately $5 million. The offering is expected to close on or about February 14, 2017. To view the full press release, visit: http://nnw.fm/oN1sN About Moleculin Biotech, Inc. Moleculin Biotech, Inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. The company’s…

Continue Reading

WednesdayFeb 08, 2017 12:23 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 8, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ONCS 12.12% – News: Presenting new clinical data at ASCO-SITC Clinical Immuno-Oncology Symposium; Presenting at two investment conferences in February STLT 12.07% – News: Engages CRO for additional preclinical mouse studies of STL-182 DFFN 11.19% – News: Clinical trial results published in February 2017 Edition of Journal of Neurosurgery LXRP 8.67% – News: Enters master collaborative research agreement with the National Research Council of Canada MEIP 7.74% – News: Posts Q2 EPS of $0.32…

Continue Reading

WednesdayFeb 08, 2017 12:22 pm

NetworkNewsBreaks – ViewRay, Inc. (NASDAQ: VRAY) Covered at Aegis with ‘Buy’ Rating, $11 PT

Aegis Capital Corp. recently initiated coverage of ViewRay (NASDAQ: VRAY), issuing a 'Buy' rating and $11 price target on the company's stock. ViewRay’s MRIdian® radiation therapy system is designed to address key restrictions of current external-beam radiation therapy technologies, and is the first of its kind to use real-time imaging that visibly defines the targeted tumor from the surrounding soft tissue and other critical organs. The company believes this will greatly improve the safety and efficacy of radiation therapy, leading to better results for patients. Most recently, the company announced that the Edogawa Hospital in Tokyo, Japan, purchased the system…

Continue Reading

WednesdayFeb 08, 2017 12:16 pm

NetworkNewsBreaks – Plug Power, Inc. (NASDAQ: PLUG) Ships First Production ProGen Engines to CA; Chinese Shipments Set For Q2 2017

Plug Power (NASDAQ: PLUG) this morning announced its shipment of the first production ProGen fuel cell engines for use in electric delivery vehicles. The first deliveries will function as range extenders in electric FedEx Freight delivery vans in and around Los Angeles, doubling the vehicle’s range. ProGen engine shipments for delivery vans in the China market begin in the second quarter of 2017 and will be utilized for on-road trials and certification. The company notes that China is actively driving fuel cell and hydrogen adoption within the country, making it an attractive market. “The electrification of the auto market is…

Continue Reading

WednesdayFeb 08, 2017 12:11 pm

NetworkNewsBreaks – RGS Energy (NASDAQ: RGSE) Shares Sink following Pricing of $6M Public Offering

Shares of RGS Energy (NASDAQ: RGSE) are down 20% mid-morning after the company announced its securities purchase agreement for a registered offering of common stock and warrants. The “Primary Units” each consist of one share of Class A common stock (par value $0.0001) and a Series M Warrant to purchase common stock. The “Alternative Units” each consist of one prepaid Series N Warrant to purchase one share of common stock and a Series M Warrant to purchase common stock. The purchase price for a Primary Unit is $2.50 per unit and the purchase price for an Alternative Unit is $2.49…

Continue Reading

WednesdayFeb 08, 2017 12:05 pm

NetworkNewsBreaks – Cellect Biotechnology (NASDAQ: APOP) Treats First Cancer Patient In Phase I/II Trial of ApoGraft™; Shares Surge

Cellect Biotechnology (NASDAQ: APOP) is trading 26% higher mid-morning following word the company has treated the first blood cancer patient in the recently initiated phase I/II trial of its stem cell technology ApoGraft™. The intent of the trial is to assess the Cellect ApoGraft™ process which is designed to prevent Graft-versus-Host Disease (GvHD), a common complication linked to stem cell transplant. Additionally, the company expects to release definitive and complete results of its trial on healthy volunteers before the end of the first quarter this year. “Enrolling our first cancer patient to be treated using our groundbreaking method is a…

Continue Reading

TuesdayFeb 07, 2017 12:38 pm

NetworkNewsBreaks – Iao Kun Group Holding Company Ltd. (NASDAQ: IKGH) Enters Chinese Technology Industry with Majority Stake in LiNiu Network

Iao Kun Group (NASDAQ: IKGH) this morning said its strategy to focus on the Chinese technology industry begins with its acquisition of a 51% interest in Jia-Heng Industrial Ltd., the holding company of Guangzhou LiNiu Network Technology Co. Ltd., a software technology development company that's developing an electronic B2C trading platform focused on the Chinese agricultural industry. Per the agreement, IKGH will issue 12.484 million ordinary shares upon the transaction’s closing, as well as cash consideration that is contingent upon LiNiu Network achieving after-tax income targets. The acquisition is expected to close in the first quarter of 2017. “After appropriate…

Continue Reading

TuesdayFeb 07, 2017 12:36 pm

NetworkNewsBreaks – Israel’s B.O.S. (NASDAQ: BOSC) Hits “Significant Milestone” with $380,000 Order from American Customer

B.O.S. Better Online Solutions ("BOS") (NASDAQ: BOSC) is trading higher after the RFID and mobile solutions provider said its Supply Chain Division has received an electronic components order from an American customer valued at $380,000. The order is anticipated to be delivered in the first quarter of 2017. “This order marks a significant milestone in our sales to the American market, as we expect it to be followed by additional orders from this customer,” BOS president Avidan Zelicovski stated in the news release. BOS is scheduled to release its fourth-quarter and fiscal year results on March 21. To view the…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000